Oncology News

In this edition, the importance of vaccination after cell therapy, artificial intelligence may help predict cardiotoxicity, experimental breast cancer vaccine generates immune response, and more.

Patients with multiple myeloma who relapse after B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy may benefit from “subsequent T-cell redirection,” according to researchers.

A greater number of live births causally reduced the risk for endometrial cancer, according to study results published in BMC Medicine.

Less than 6% of eligible Americans have undergone lung cancer screening, according to American Lung Association’s 2022 State of Lung Cancer report.

In this episode, data show ‘critical need’ for universal genetic testing; patients with inflammatory breast cancer at high risk for brain metastases; palbociclib fails to benefit breast cancer subgroup and more.

In this edition, FDA approves Tecvayli for multiple myeloma, radiation and hormone therapy slows progression of prostate cancer, and more.

Deepa R. Halaharvi, DO, was diagnosed with stage I breast cancer just 8 months after starting her career as a breast surgeon. Now, Halaharvi uses her experience to help others who are diagnosed.

Jansen Biotech said its drug Tecvayli received accelerated approval from the FDA after data showed that it benefited patients with relapsed or refractory multiple myeloma.

ANAHEIM, Calif. — In this video exclusive, Francesca Barrett, MD, MBA, discusses concerns with fertility preservation and posthumous use of assisted reproductive technologies for adolescents and young adults with poor cancer prognoses.

In this episode, host Shikha Jain, MD, speaks with retired Commanding General of the US Army, Lieutenant General Mark Hertling, about the similar responsibilities of doctors and soldiers, what makes a strong leader in the health care space and more.